CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
| Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
| Scripps Research Institute |
Peter G. Schultz |
Research Training Grant |
Training Scholars in Regenerative Medicine and Stem Cell Research |
$5,304,759 |
| University of California, San Diego |
Professor Alysson R Muotri |
Research Training Grant |
Interdisciplinary Stem Cell Training Grant at UCSD III |
$5,366,188 |
| Children’s Hospital of Los Angeles |
Dr Ching-Ling Lien Ph.D. |
Research Training Grant |
CIRM Training Program for Stem Cell and Regenerative Medicine Research |
$5,373,242 |
| University of California, Davis |
Dr Jan A Nolta |
Research Training Grant |
CIRM Cell and Gene Therapy Training Program 2.0 |
$5,013,550 |
| University of California, Berkeley |
Dirk Hockemeyer |
Research Training Grant |
Training the Next Generation of Biologists and Engineers for Regenerative Medicine |
$5,327,980 |
| Stanford University |
Tushar Desai |
Research Training Grant |
CIRM Scholar Training Program |
$5,347,815 |
| City of Hope, Beckman Research Institute |
Dr. Michael E. Barish Ph, D. |
Research Training Grant |
Research Training Program in Stem Cell Biology and Regenerative Medicine |
$5,234,731 |
| Gladstone Institutes, J. David |
Dr. Bruce R. Conklin |
Research Training Grant |
CIRM Regenerative Medicine Research Training Program |
$5,373,742 |
| University of California, Santa Cruz |
Dr. Camilla Forsberg |
Research Training Grant |
CIRM Training Program in Systems Biology of Stem Cells |
$5,278,566 |
| University of Southern California |
Dr. Francesca Mariani |
Research Training Grant |
Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine |
$5,373,742 |
| University of California, Los Angeles |
William Lowry |
Research Training Grant |
UCLA Training Program in Stem Cell Biology |
$5,373,742 |
| The Regents of the University of California on behalf of its Riverside Campus |
Dr. Prue Talbot |
Research Training Grant |
TRANSCEND – Training Program to Advance Interdisciplinary Stem Cell Research, Education, and Workforce Diversity |
$5,344,306 |
| Cedars-Sinai Medical Center |
Cedars-Sinai Medical Center Wafa Tawackoli |
Research Training Grant |
CIRM Training Program in Translational Regenerative Medicine |
$5,373,075 |
| Boston Children’s Hospital |
Dr. David Williams M.D. |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
Phase 2 Study of Hematopoietic Stem Cell Gene Transfer Inducing Fetal Hemoglobin in Sickle Cell Disease |
$8,333,581 |
| University of California, San Francisco |
Mark C. Walters M.D. |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease |
$8,389,407 |
| University of California, Irvine |
Daniela A. Bota |
Alpha Stem Cell Clinics Network Expansion |
A hub and spoke community model to equitably deliver regenerative medicine therapies to diverse populations across four California counties |
$8,000,000 |
| University of Southern California |
Thomas Buchanan |
Alpha Stem Cell Clinics Network Expansion |
Alpha Clinic Network Expansion for Cell and Gene Therapies |
$7,999,983 |
| University of California, Los Angeles |
Dr. Noah Carvajal Federman |
Alpha Stem Cell Clinics Network Expansion |
Expansion of the Alpha Stem Cell and Gene Therapy Clinic at UCLA |
$8,000,000 |
| University of California, San Diego |
Dr. Catriona Jamieson |
Alpha Stem Cell Clinics Network Expansion |
UC San Diego Health CIRM Alpha Stem Cell Clinic |
$8,000,000 |
| University of California, Davis |
Dr Mehrdad Abedi |
Alpha Stem Cell Clinics Network Expansion |
Alpha Stem Cell Clinic for Northern and Central California |
$7,999,997 |
| City of Hope, Beckman Research Institute |
Dr. Leo D Wang |
Alpha Stem Cell Clinics Network Expansion |
The City of Hope Alpha Clinic: A roadmap for improving access to regenerative medicine therapies for all Californians |
$8,000,000 |
| Cedars-Sinai Medical Center |
Dr. Michael I Lewis |
Alpha Stem Cell Clinics Network Expansion |
A comprehensive stem cell and gene therapy clinic to advance new therapies for a diverse patient population in California |
$7,957,966 |
| University of California, San Francisco |
Mark C. Walters M.D. |
Alpha Stem Cell Clinics Network Expansion |
University of California, San Francisco (UCSF) Alpha Stem Cell Clinic (ASCC) |
$7,994,347 |
| Stanford University |
Dr. Matthew H Porteus |
Alpha Stem Cell Clinics Network Expansion |
The Stanford Alpha Stem Cell Clinic |
$6,920,810 |
| Generation STEAM |
Silvana DelPiccolo |
Conference – 2026 SPARK Annual Meeting |
Manage the 2025 Annual SPARK Conference |
$114,000 |
| University of California, Irvine |
Dr. Aileen J Anderson |
Quest – Discovery Stage Research Projects |
Therapeutic targeting of Glioblastoma Stem Cell survival and self-renewal signaling |
$2,250,144 |
| Children’s Hospital of Los Angeles |
Dr Biraj Mahato |
Quest – Discovery Stage Research Projects |
Chemically engineered photoreceptors for vision restoration in retinal degeneration associated blindness. |
$1,711,000 |
| University of California, San Francisco |
Claire Clelland |
Quest – Discovery Stage Research Projects |
Developing a universal CRISPR gene therapy approach to treat C9orf72 ALS |
$2,740,592 |
| University of California, Los Angeles |
Dr. Koki Morizono |
Quest – Discovery Stage Research Projects |
B cell receptor-mediated lentiviral expression of anti-HIV antibody |
$2,751,504 |
| City of Hope, Beckman Research Institute |
Dr. Christine E. Brown |
Quest – Discovery Stage Research Projects |
Development of a Trifunctional Self-Renewing Memory CAR T Cell Therapy to Overcome the Heterogeneity and Suppressive Microenvironment of Glioblastoma |
$2,700,810 |
| University of California, San Francisco |
Faranak Fattahi |
Quest – Discovery Stage Research Projects |
Drug discovery for Charcot Marie Tooth Disease using hPSC-derived Schwann cells |
$2,471,664 |
| University of California, San Diego |
Dr. Neil Carson Chi |
Quest – Discovery Stage Research Projects |
Modulating cardiac myosin heavy chain isoform expression for treating cardiomyopathies |
$2,772,000 |
| University of California, San Francisco |
Dr. Qizhi Tang PhD |
Quest – Discovery Stage Research Projects |
Genome editing of human Tregs to enable combinational tolerogenic therapy with T cell-targeted biologics for T1D |
$2,485,549 |
| Palo Alto Veterans Institute for Research |
Dr. Jian Luo |
Quest – Discovery Stage Research Projects |
Human induced pluripotent stem cells-derived glial enriched progenitors for the treatment of mild traumatic brain injury |
$2,255,189 |
| Palo Alto Veterans Institute for Research |
Irene Lorenzo Llorente |
Quest – Discovery Stage Research Projects |
Inhibitory interneurons derived from human induced pluripotent stem cells to treat stroke |
$2,140,122 |
| Savanna Biotherapeutics, Inc. |
Dr. Sunil Gandhi Ph.D |
Quest – Discovery Stage Research Projects |
Gene-corrected human microglia for the treatment of adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) |
$1,417,948 |
| University of California, San Francisco |
Faranak Fattahi |
Quest – Discovery Stage Research Projects |
Drug discovery for gastrointestinal motility disorders using hPSC-derived enteric ganglioids |
$1,954,367 |
| Cedars-Sinai Medical Center |
Dr. Ritchie Ho |
Quest – Discovery Stage Research Projects |
C9orf72 repeat expansion-tuned allelic suppression by CRISPRi as an ALS therapy |
$2,274,768 |
| University of Southern California |
Dr. Justin K Ichida |
Quest – Discovery Stage Research Projects |
Development of a VAV2 antisense oligonucleotide (ASO) treatment for ALS |
$2,072,560 |
| University of California, Davis |
Ricardo Anibal Maselli MD |
Quest – Discovery Stage Research Projects |
Treatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy |
$1,500,000 |
| Adverum Biotechnologies Inc. |
Cameron Keast Baker |
Quest – Discovery Stage Research Projects |
Development of an Optogenetic Vision Restoration Gene Therapy Using an Engineered Form of Melanopsin |
$1,150,820 |
| Stanford University |
Dr. Robert Negrin MD |
Quest – Discovery Stage Research Projects |
Orthogonal IL2 Receptor Transduced Regulatory T Cells for Clinical Application |
$1,920,652 |
| University of California, San Francisco |
Michael Wilson |
Quest – Discovery Stage Research Projects |
A First-in-Class Treatment for Progressive Multifocal Leukoencephalopathy Via Multimodal Immune System Engineering |
$2,182,396 |
| Stanford University |
Dr. Michael F Clarke |
Quest – Discovery Stage Research Projects |
Developing a breast cancer stem cell drug |
$2,053,727 |
| Cedars-Sinai Medical Center |
Dr. Ke Liao |
Quest – Discovery Stage Research Projects |
RNA-based therapeutics to augment regulatory T cells: a novel approach to treat myocarditis |
$2,264,509 |
| University of Southern California |
Dr Linda Sher M.D. |
Quest – Discovery Stage Research Projects |
Assessing the Functional, Immunologic and Microbiologic Characteristics of Human Livers Created in Chimeric Pigs |
$2,736,590 |
| University of California, Irvine |
Jianhua Yu |
Quest – Discovery Stage Research Projects |
Reprogramming Somatic Cells into iPSCs Engineered with an Anti-PSCA CAR to Develop Allogeneic Off-the-Shelf Cell Therapy to Treat Pancreatic Cancer |
$1,509,000 |
| Gladstone Institutes, J. David |
Lyandisha Zholudeva |
Quest – Discovery Stage Research Projects |
Excitatory spinal interneurons from human pluripotent stem cells to treat spinal cord injury |
$2,942,198 |
| University of California, Los Angeles |
Prof. Song Li |
Quest – Discovery Stage Research Projects |
Vax-CT to promote formation of cancer-specific T memory stem cell for personalized cancer immunotherapy |
$2,267,714 |
| University of California, Los Angeles |
Dr. Richard Joseph Pietras |
Quest – Discovery Stage Research Projects |
Reversal of dysregulated myelopoiesis in breast cancers and cancer stem cells to boost antitumor immunotherapy |
$2,327,680 |
